Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PROTHENA CORP PUBLIC LTD CO Director's Dealing 2017

May 19, 2017

32782_dirs_2017-05-19_9226ea21-ae21-45e7-a09f-5feeb27a3bf7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Prothena Corp plc (PRTA)
CIK: 0001559053
Period of Report: 2017-05-18

Reporting Person: Harfstrand Karl Anders Olof (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-05-18 Stock Option (right to buy) $56.23 A 12000 Acquired 2027-05-18 Ordinary Shares (12000) Direct

Footnotes

F1: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual general meeting in 2018 of the Issuer's shareholders, assuming continuous service as a director until such vesting date.